Where is Covance located?

Covance is headquartered in Princeton, United States.

Is Covance a funded company?

Covance is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Covance rank among its competitors?

Covance ranks 312th amongst 303 active competitors, of which 55 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Verily, which secured $300M in Mar, 2026.

Who are the top competitors of Covance?

Covance's top competitors include Medidata, IQVIA and Verily. Among them, Verily secured the most recent funding round in March, 2026.

Covance - 2026 Company Profile & Competitors

Covance is an unfunded company based in Princeton (United States), founded in 2019. It operates as a Provider of clinical trial management solutions for research clinics. Covance has not raised any funding yet. The company has 303 active competitors, including 55 funded and 42 that have exited. Its top competitors include companies like Medidata, IQVIA and Verily.

Company Details

Website: ingenuityfour.com
Part Of

Key Metrics

Founded Year

2019

Location

Princeton, United States

Stage

Unfunded

Ranked

312^th among 348 competitors

Similar Companies

Medidata & 346 more

View Covance's full profile

Covance has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Covance include Medidata, IQVIA and Verily. Here is the list of Top 10 competitors of Covance, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Medidata 1999, New York City (United States), Acquired	AI-based clinical trial management software for researchers	$41.5M	Insight Partners, TFS & 11 others	86/100
2nd	IQVIA 1982, Durham (United States), Public	Provider of clinical research and commercialization solutions for healthcare	$1.74M	Leonard Green and Partners, Morgan Stanley ... & 12 others	80/100
3rd	Verily 2015, Dallas (United States), Series D	A data platform and technology company purpose-built to power AI-enabled precision health	$2.8B	Silver Lake, Temasek & 9 others	78/100
4th	Tempus 2015, Chicago (United States), Public	Developer of genomic testing and artificial intelligence tools for medicine	$1.05B	New Enterprise Associates, T. Rowe Price ... & 11 others	74/100
5th	Signant Health 2000, Plymouth Meeting (United States), Acquired	Provider of a software solution for clinical trial management	$3.4M	Harvest Partners, 3i Group & 4 others	72/100
6th	Science 37 2014, Los Angeles (United States), Acquired	Provider of a suite solution for clinical trials for researchers	$106M	Redmile Group, Lux Capital & 12 others	70/100
7th	Viz.ai 2016, San Francisco (United States), Series D	Developer of an AI-powered platform for care coordination and disease detection	$252M	Insight Partners, Tiger Global Management ... & 16 others	69/100
8th	TriNetX 2013, Cambridge (United States), Acquired	Provider of clinical trial management software for researchers and professionals	$102M	Merck Global Health Innovation Fund, MPM Capital ... & 6 others	66/100
9th	BrightInsight 2017, San Jose (United States), Series C	Provider of digital health solutions for clinical trials	$179M	General Catalyst, Insight Partners & 8 others	64/100
10th	Wcg Clinical 2012, Princeton (United States), Acquired	CRO offering regulatory and ethical review services for clinical research	-	Ares Capital Corporation, Prospect Capital ... & 6 others	64/100
312th	Covance 2019, Princeton (United States), Unfunded	Provider of clinical trial management solutions for research clinics	-	-	16/100